E-mail

E-mail a Wiley Online Library Link

Stephen J. Freedland, Alan W. Partin, Elizabeth B. Humphreys, Leslie A. Mangold and Patrick C. Walsh Radical prostatectomy for clinical stage T3a disease Cancer 109

Version of Record online: 21 FEB 2007 | DOI: 10.1002/cncr.22544

The outcomes among a select cohort of 56 men with clinical stage T3a disease treated by radical prostatectomy from 1987 to 2003 were examined. After 15 years of follow-up after surgery the prostate-specific antigen (PSA)-free survival was 49%, 27% had metastasis, and only 16% had died from prostate cancer. The study suggests that radical prostatectomy may be a feasible option for select men with clinical stage T3a disease.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH